![Christian Bailey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christian Bailey
Private Equity Investor bij UP Partners Management Co. LLC
Actieve functies van Christian Bailey
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UP Partners Management Co. LLC
![]() UP Partners Management Co. LLC Investment ManagersFinance UP Partners Management Co. LLC (UP Partners) is a venture capital firm founded in 2019 by Cyrus Sigari and Ben Marcus. The firm is headquartered in Santa Monica, California. | Private Equity Investor | 01-07-2020 | - |
Loopbaan van Christian Bailey
Eerdere bekende functies van Christian Bailey
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Ligon Discovery, Inc.
![]() Ligon Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Ligon Discovery's primary technology platform, Small-Molecule Microarrays (SMMs), fundamentally transforms drug discovery by bringing the power of microarrays to target screening. SMMs, developed at Harvard University and the Broad Institute, use a proprietary surface chemistry to attach unmodified chemical collections to a solid surface, enabling massively-parallel screening against protein targets of any function. The scale and scope of SMMs permit a paradigmatic change in drug discovery strategy as entire protein families, molecular pathways, and even genome-wide target sets can be screened in parallel to rapidly identify small molecules with optimal characteristics for drug development. Ligon is applying SMM technology to challenging, novel targets aimed at discovery of first-in-class drugs for oncology and other selected diseases. Ligon Discovery's SMM platform is available for drug discovery collaborations. | Algemeen Directeur | 01-06-2010 | 01-12-2011 |
Oprichter | 01-06-2010 | 01-12-2011 | |
Lincoln Asset Management Group LLC
![]() Lincoln Asset Management Group LLC Investment ManagersFinance Founded by Christian Bailey, Lincoln Asset Management Group LLC is a hedge fund manager located in New York City. They manage the Lincoln Vector Fund LP and the Lincoln Futures Fund. | Chief Investment Officer | - | - |
Portefeuillebeheerder-Aandelen | - | - | |
President | - | - | |
incTANK Inc
![]() incTANK Inc Investment ManagersFinance incTANK Inc (incTANK) is a venture capital firm founded in 1999 by Karl H. Ruping. The firm is headquartered in the Cambridge, Massachusetts. | Private Equity Investor | 08-12-2010 | - |
Opleiding van Christian Bailey
University of Oxford | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Verenigd Koninkrijk | 2 |
Operationeel
Private Equity Investor | 2 |
Chief Investment Officer | 1 |
Portfolio Manager-Equities | 1 |
Sectoraal
Finance | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Lincoln Asset Management Group LLC
![]() Lincoln Asset Management Group LLC Investment ManagersFinance Founded by Christian Bailey, Lincoln Asset Management Group LLC is a hedge fund manager located in New York City. They manage the Lincoln Vector Fund LP and the Lincoln Futures Fund. | Finance |
incTANK Inc
![]() incTANK Inc Investment ManagersFinance incTANK Inc (incTANK) is a venture capital firm founded in 1999 by Karl H. Ruping. The firm is headquartered in the Cambridge, Massachusetts. | Finance |
UP Partners Management Co. LLC
![]() UP Partners Management Co. LLC Investment ManagersFinance UP Partners Management Co. LLC (UP Partners) is a venture capital firm founded in 2019 by Cyrus Sigari and Ben Marcus. The firm is headquartered in Santa Monica, California. | Finance |
Ligon Discovery, Inc.
![]() Ligon Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Ligon Discovery's primary technology platform, Small-Molecule Microarrays (SMMs), fundamentally transforms drug discovery by bringing the power of microarrays to target screening. SMMs, developed at Harvard University and the Broad Institute, use a proprietary surface chemistry to attach unmodified chemical collections to a solid surface, enabling massively-parallel screening against protein targets of any function. The scale and scope of SMMs permit a paradigmatic change in drug discovery strategy as entire protein families, molecular pathways, and even genome-wide target sets can be screened in parallel to rapidly identify small molecules with optimal characteristics for drug development. Ligon is applying SMM technology to challenging, novel targets aimed at discovery of first-in-class drugs for oncology and other selected diseases. Ligon Discovery's SMM platform is available for drug discovery collaborations. | Commercial Services |
- Beurs
- Insiders
- Christian Bailey
- Ervaring